Metabolic Disorders in Multiple Myeloma
Multiple myeloma (MM) is the second most common hematological malignancy and is attributed to monoclonal proliferation of plasma cells in the bone marrow. Cancer cells including myeloma cells deregulate metabolic pathways to ensure proliferation, growth, survival and avoid immune surveillance, with...
Saved in:
Main Authors: | Maria Gavriatopoulou, Stavroula A. Paschou, Ioannis Ntanasis-Stathopoulos, Meletios A. Dimopoulos |
---|---|
Format: | article |
Language: | EN |
Published: |
MDPI AG
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/09e31b8548c4455aae403a9d8e95af86 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Advances in improving mammalian cells metabolism for recombinant protein production
by: Altamirano,Claudia, et al.
Published: (2013) -
Nitric Oxide Circumvents Virus-Mediated Metabolic Regulation during Human Cytomegalovirus Infection
by: Rebekah L. Mokry, et al.
Published: (2020) -
Expression of STOML2 promotes proliferation and glycolysis of multiple myeloma cells via upregulating PAI-1
by: Hongxia Zhang, et al.
Published: (2021) -
Macroglossia reveals multiple myeloma
by: Maria Bonvicini, et al.
Published: (2021) -
IMMUNE DISTURBANCES IN PATIENTS WITH MULTIPLE MYELOMA
by: E. A. Senkina, et al.
Published: (2014)